Skip to content

Clinical trials

Pulmonary Arterial Hypertension trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Clear all

691 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20037
20046
20058
200619
200717
200825
200918
201040
201140
201231
201336
201423
201530
201626
201737
201838
201940
202020
202139
202228
202337
202431
202531
202653

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed340
Terminated84
Unknown status79
Recruiting78
Not yet recruiting41
Withdrawn37
Active, not recruiting22
No longer available5
Enrolling by invitation4
Available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion59
United Therapeutics44
Bayer19
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.13
Bial - Portela C S.A.12
Merck Sharp & Dohme LLC12
Novartis Pharmaceuticals12
Assistance Publique - Hôpitaux de Paris10
Pfizer10
University of Sao Paulo General Hospital10

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension691
Hypertension, Pulmonary185
Familial Primary Pulmonary Hypertension32
Heart Failure18
Lung Diseases, Interstitial18
Lung Diseases16
Cardiovascular Diseases15
Heart Defects, Congenital15
Hypertension15
Connective Tissue Diseases13

Trials

Showing 51 to 75 of 691. Each trial links to its page on Pharma Observatory.

591 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.